PEGASUS ASSET MANAGEMENT, INC. – Relmada Therapeutics, Inc. Transaction History
PEGASUS ASSET MANAGEMENT, INC. portfolio value:
$998,000
portfolio value
PEGASUS ASSET MANAGEMENT, INC. quarter portfolio value change:
+94.94%
quarter
Relmada Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | 486K | $37.02 | 26.95K | |
Q2 2022 | share | 0.00% | 0 shares | -216K | $18.99 | 26.95K | |
Q1 2022 | share | 0.00% | 0 shares | 121K | $26.99 | 26.95K | |
Q4 2021 | share | 0.00% | 0 shares | -100K | $21.71 | 26.95K | |
Q3 2021 | share | 0.00% | 0 shares | -156K | $26.21 | 26.95K | |
Q2 2021 | share | 0.00% | 0 shares | -86K | $32.01 | 26.95K | |
Q1 2021 | share | 0.00% | 0 shares | 84K | $35.21 | 26.95K | |
Q4 2020 | share | 0.00% | 0 shares | -149K | $32.07 | 26.95K | |
Q3 2020 | share | 0.00% | 0 shares | -192K | $37.62 | 26.95K | |
Q2 2020 | share | Increase | 0.00% | 26.95K shares | 1.20M | $44.75 | 26.95K |